A Phase 2, Double-blind, Randomized, Placebo-Controlled, Daily-dose, Proof-of-concept Study of a Vitamin D Compound in Postmenopausal Women With Osteopenia
Latest Information Update: 08 Nov 2021
At a glance
- Drugs DP 001 (Primary)
- Indications Metabolic bone diseases; Postmenopausal osteoporosis
- Focus Therapeutic Use
Most Recent Events
- 29 Mar 2010 New trial record